Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2

Dristhi Ragoonanan, Sajad J. Khazal, Rodrigo Mejia, Linette Ewing, Jean Bernard Durand, Lara Bashoura, Jean Tayar, Natalie Dailey Garnes, Demetrios Petropoulos, Priti Tewari, Micah Bhatti, Ali Haider Ahmad, Jose Cortes, Shehla Razvi, Katrina McBeth, Rita Swinford, Basirat Shoberu, Waseem Waseemuddin, Linda Chi, Jonathan B. GillWafik Zaky, Najat Daw, Cristina Gutierrez, Welela Tereffe, Partow Kebriaei, Katayoun Rezvani, Elizabeth J. Shpall, Richard E. Champlin, Kris M. Mahadeo

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Article number625707
JournalFrontiers in Oncology
Volume11
DOIs
StatePublished - Feb 4 2021
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • COVID-19
  • MIS-A
  • MIS-C
  • SARS-CoV-2
  • cancer immunotherapy

Cite this